Search for:
Category

Product Regulation & Liability

Category
In Anti-Corruption

Asia Pacific: 5 Lunar New Year’s resolutions for investigations

by , , and 2 Mins Read

Investigations are an essential tool for ensuring a company’s ethical standards are being followed by employees, business partners, and any others with whom the company interacts. However, investigations are also an essential tool for demonstrating and maintaining strong corporate governance – an integral part of a company’s ESG commitments and strategy. It is also a good time to set yourself some goals and resolutions. To help you on your way, we are pleased to share our top 5 Lunar New Year Resolutions for handling Internal or Government Investigations

Read More
In Product Regulation & Liability

Spain: The Canary Islands change the game rules for taxation in the healthcare sector

by , , , and 4 Mins Read

The Canary Islands Government has decided to reduce the tax rate applicable to different goods and services including medical devices, veterinary medicines and veterinary services. These changes are expected to facilitate patients’ access to these products and services by reducing their costs.

In

Global: World Health Organization releases AI ethics and governance guidance for large multimodal models

by and 5 Mins Read

On 18 January 2024, the World Health Organization issued new guidance on the ethics and governance of artificial intelligence for health, focusing on large multimodal models (LMMs). The WHO guidance summarizes the broad applications of LMMs in the healthcare industry and includes recommendations for governments, which have the primary responsibility of setting standards for the development and deployment of LMMs, and their integration and use for public health and medical purposes.

Read More
In Product Regulation & Liability

Italy: New regulation on the organization of the Italian Medicines Agency

by , and 2 Mins Read

On 15 January 2024, the Decree of the Minister of Health No. 3 of 8 January 2024 on “Changes to the regulation on the organization and functioning of the Italian Medicines Agency” was published in the Official Gazette. The Decree will enter into force on 30 January 2024. The Decree provides, amongst other things, for the abolition of the role of General Director (while the position of the President as the body and legal representative of the Agency is maintained) and the creation of the management positions of the Administrative Director and the Technical-Scientific Director.

In Product Regulation & Liability

Italy: The Ministry of Foreign Affairs launches a round table for the internationalization of the biotechnology sector

by , and 1 Min Read

After the Conference on Emerging Biotechnology held on 14 November 2023, the Ministry of Foreign Affairs launched a round table for the internationalization of the biotechnology sector, which met for the first time on 9 January 2024. The round table was established in order to identify strategies and provide recommendations for those working in the field of biotechnology, with the aim of strengthening the national sector and stimulating the development of innovative supply chains and emerging technologies.

Read More
In Product Regulation & Liability

Italy: The protocol on institutional collaboration in the healthcare procurement sector has been signed

by , and 1 Min Read

On 15 January 2024, Consip S.p.A. and Confindustria Dispositivi Medici (the Italian Association of Medical Device Companies) signed an institutional collaboration agreement aimed at identifying the best procurement opportunities for public administrations in the healthcare sector.

In Product Regulation & Liability

Italy: The Italian Medicines Agency updates operating instructions related to the import and the export of human blood and blood components

by , and 1 Min Read

On 21 December 2023, the Italian Medicines Agency updated the operating instructions and forms that can be used for the submission to the Biological Medicinal Product Evaluation Office of the documentation regarding the import and the export of human blood and blood components.

In Product Regulation & Liability

Global: WHO – New guidance on the ethics and governance of large multi-modal models of AI (LMMs)

by , and 2 Mins Read

On 18 January 2024, the World Health Organization (WHO) published a New Guidance on the ethics and governance of large multi-modal models (LMMs) of Artificial Intelligence (AI), targeting governments, technology companies and healthcare providers to promote the appropriate use of AI and protect public health.

Read More
Load More